MedTrace Logo

PRP Intrauterine Infusion in Thawed Embryo Cycles

NCT03734042 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2021-11-29

No results posted yet for this study

Summary

All patients prepared to thawed embryo transfer were classified into 2 groups one group will receive platelet rich plasma (PRP) infusion intrauterine and the other group will not receive platelet rich plasma (PRP) infusion

Conditions

  • Evaluations

Interventions

BIOLOGICAL

Platelet rich plasma intrauterine infusion

platelet rich plasma will be prepared, activated then infused by Intrauterine insemination catheter intrauterine at day 11

BIOLOGICAL

Normal saline

Intrauterine infusion of normal saline at day 11

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-01
Primary Completion
2021-10-31
Completion
2021-10-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03734042 on ClinicalTrials.gov